Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors.

Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors. Clin Cancer Res. 2014 Oct 15; 20(20):5290-301.

View in: PubMed

subject areas

Animals
Antibodies, Monoclonal
Antineoplastic Agents
B7-H1 Antigen
Brain Neoplasms
Cell Line, Tumor
CTLA-4 Antigen
Dacarbazine
Disease Models, Animal
Drug Therapy, Combination
Glioma
Indoleamine-Pyrrole 2,3,-Dioxygenase
Mice
Mice, Knockout
T-Lymphocytes, Regulatory

authors with profiles

Derek A. Wainwright